Roswell Park's Phase 1 Trial Results For Triple-Negative Breast Cancer, With 66% Achieving Complete Or Near-Complete Remission And No Immune-Related Adverse Events; Findings Published In Journal For ImmunoTherapy Of Cancer
Roswell Park's Phase 1 Trial Results For Triple-Negative Breast Cancer, With 66% Achieving Complete Or Near-Complete Remission And No Immune-Related Adverse Events; Findings Published In Journal For ImmunoTherapy Of Cancer
羅斯韋爾公園針對三陰性乳腺癌的1期試驗結果顯示，66%的患者完全或近乎完全緩解，並且沒有免疫相關的不良事件；研究結果發表在《癌症免疫治療雜誌》上
Roswell Park's Phase 1 Trial Results For Triple-Negative Breast Cancer, With 66% Achieving Complete Or Near-Complete Remission And No Immune-Related Adverse Events; Findings Published In Journal For ImmunoTherapy Of Cancer
羅斯韋爾公園針對三陰性乳腺癌的1期試驗結果顯示，66%的患者完全或近乎完全緩解，並且沒有免疫相關的不良事件；研究結果發表在《癌症免疫治療雜誌》上
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間